Atlas Trials

BinYong Liang

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch BinYong Liang

RecordFirmDate
Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma (NCT07522411)BinYong Liang2026-04-30

Track BinYong Liang automatically

Every clearance here is in the API, with alerts when new ones post.